Correlation of Complement Activating Donor Specific Antibodies as Measured by C3d and Cross-Match Status

被引：0
|
作者：
Babu, A. [1 ,2 ,3 ]
Krishnan, N. [2 ]
Briggs, D. [3 ]
Mitchell, D. [1 ]
Daga, S. [1 ,2 ,4 ]
机构：
[1] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England
[2] Univ Hosp Coventrya & Warwickshire, Nephrol & Transplantat, Coventry, W Midlands, England
[3] NHS Blood & Transfus, Histocompatibil & Immunogenet, Birmingham, W Midlands, England
[4] Leeds Teaching Hosp NHS Trust, Nephrol & Transplantat, Leeds, W Yorkshire, England
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C14
引用
收藏
页码：620 / 620
页数：1
相关论文
共 50 条
  • [31] Polyreactive Antibodies Generated Amidst Rejection of Human Kidney Grafts Activate Complement and Deposit C3d/C4d
    Fraser, J. W.
    Hastings, C.
    Porcheray, F.
    DeVito, J.
    Dargon, I.
    Helou, Y.
    Ferdman, J.
    Smith, R. N.
    Zorn, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 419 - 420
  • [32] CLINICAL RISK STRATIFICATION OF PAEDIATRIC RENAL TRANSPLANT RECIPIENTS USING C1Q AND C3D FIXING OF DONOR SPECIFIC ANTIBODIES.
    Kim, J. J.
    Shaw, O.
    Martin, C.
    Michaelides, G.
    Balasubramaniam, R.
    Sebire, N. J.
    Mamode, N.
    Dorling, A.
    Vaughan, R.
    Marks, S. D.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 42 - 42
  • [33] Impact of positive donor-specific HLA antibodies (DSA) cross-match on graft survival in ABO incompatible liver-kidney transplantation: a case report
    Lin, P. -Y
    Hsieh, C-E
    Yang, Y.
    Lin, K. -H
    Chen, Y. -L
    TRANSPLANTATION, 2018, 102 : 341 - 341
  • [34] Novel monoclonal antibodies to C3d for non-invasively monitoring the activity of complement in glomerular and retinal disease
    Rohrer, B.
    Kulik, L.
    Mitchell, L. M.
    Hourcade, D. E.
    Hannan, J. P.
    Coughlin, B.
    Woodell, A. S.
    Pickering, M. C.
    Holers, V. M.
    Thurman, J. M.
    MOLECULAR IMMUNOLOGY, 2013, 56 (03) : 264 - 264
  • [35] CLINICAL RISK STRATIFICATION OF PAEDIATRIC RENAL TRANSPLANT RECIPIENTS USING C1Q AND C3D FIXING OF DE NOVO DONOR SPECIFIC ANTIBODIES
    Kim, Jon Jin
    Shaw, Olivia
    Martin, Chloe
    Michaelides, George
    Sebire, Neil
    Mamode, Nizam
    Dorling, Anthony
    Vaughan, Robert
    Marks, Stephen
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1801 - 1801
  • [36] CLINICAL SIGNIFICANCE OF C3D BINDING DONOR SPECIFIC ANTI-HLA ANTIBODIES DETECTED BY SINGLE ANTIGEN BEADS AFTER KIDNEY TRANSPLANTATION
    Steller, Paula
    Pelletier, Ronald P.
    Balazs, Ivan
    DiPaola, Nicholas
    Adams, Patrick W.
    Diez, Alejandro
    Henry, Mitchell
    HUMAN IMMUNOLOGY, 2016, 77 : 18 - 18
  • [37] Donor Specific Antibodies Detected by SAB Prior to Kidney Transplant Represent Minimal Risk Unless Associated with a Positive Cell-Based Flow Cytometry Cross-Match
    Cooper, J. E.
    Gralla, J.
    Chan, L.
    Wiseman, A. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 411 - 411
  • [38] BLOCKING EFFECT OF ANTIBODIES AGAINST THE PRODUCTS OF THE H-2-GENE COMPLEX ON LYMPHOCYTE COMPLEMENT (C3D) RECEPTORS - COMPLEMENT DEPENDENCE AND SPECIFICITY
    BISHOP, C
    DEMANT, P
    CAPEL, PJA
    TISSUE ANTIGENS, 1980, 15 (01): : 31 - 39
  • [39] Correlation between expression of regulators of complement activation, deposition of complement markers C4d and C3d and cardiac allograft dysfunction in multiparous heart transplant recipients
    Rodriguez, E. R.
    Baldwin, W. M.
    Tan, C. D.
    LABORATORY INVESTIGATION, 2008, 88 : 66A - 66A
  • [40] Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies
    Kim, Jon Jin
    Shaw, Olivia
    Martin, Chloe
    Michaelides, George
    Balasubramaniam, Ramnath
    Sebire, Neil J.
    Mamode, Nizam
    Dorling, Anthony
    Vaughan, Robert
    Marks, Stephen D.
    PEDIATRIC NEPHROLOGY, 2018, 33 (01) : 167 - 174
12345